Skip to main content
. 2016 Oct 22;16:103. doi: 10.1186/s12871-016-0266-2

Fig. 3.

Fig. 3

Variation in median dose of intermediate duration neuromuscular blocking agents (NMBs) indexed to Ideal Body Weight (IBW) and Neostigmine dose indexed to Total Body Weight (TBW) across Body Mass Index (BMI) categories [6, 1417]. * Cisatracurium doses represent the total amount of drug given (infusions and boluses)